Synta Pharmaceuticals , Nasdaq: SNTA
A biotech developing drugs for chronic inflammatory diseases and cancer.
Industry: Health Care
First Day Return: -9.1%
Industry: Health Care
SNTA
A biotech developing drugs for chronic inflammatory diseases and cancer.
| IPO Data | |
|---|---|
| IPO File Date | 11/22/2006 |
| Offer Price | $10.00 |
| Price Range $14.00 - $16.00 | |
| Offer Shares (mm) | 5.0 |
| Deal Size ($mm) | $50 |
| Lock-Up Date | IPO Pro Only |
| Street Research | IPO Pro Only |
| IPO Data | |
|---|---|
| IPO Date | 02/05/2007 |
| Offer Price | IPO Intelligence Only |
| Price Range | IPO Intelligence Only |
| Offer Shares (mm) | IPO Intelligence Only |
| Deal Size ($mm) | $50 |
| Lock-Up Date | IPO Intelligence Only |
| Street Research | IPO Intelligence Only |
| Underwriters |
|---|
| IPO Intelligence Only |
| Company Data | |
|---|---|
| Headquarters | Lexington, MA, United States |
| Founded | 2001 |
| Employees at IPO | n/a |
| Website www.syntapharma.com | |
IPO News for Synta Pharmaceuticals
Synta Pharmaceuticals (SNTA) Performance
